These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 913860)

  • 1. Serum levels and urinary concentrations of kanamicin, bekanamicin and amikacin (BB-K8) in diabetic children and a control group.
    García G; de Vidal EL; Trujillo H
    J Int Med Res; 1977; 5(5):322-9. PubMed ID: 913860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of amikacin and kanamycin.
    Kirby WM; Clarke JT; Libke RD; Regamey C
    J Infect Dis; 1976 Nov; 134 SUPPL():S312-5. PubMed ID: 993624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of kanamycin and amikacin in human gallbladder bile and wall.
    Hansbrough JF; Clark JE; Reimer LG
    Antimicrob Agents Chemother; 1981 Oct; 20(4):515-7. PubMed ID: 7342877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of amikacin in serum, muscle, and fat in children after a single intramuscular injection.
    Daschner F; Reiss E; Engert J
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1081-3. PubMed ID: 879756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amikacin concentration in the severely obstructed urinary tract].
    Yamasaki Y; Arima K; Ogawa H; Hori N; Kinoshita N; Katoh M; Tochigi H; Tada S
    Hinyokika Kiyo; 1984 Aug; 30(8):1127-34. PubMed ID: 6517002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of absorption and excretion of powdery preparation for injection and liquid preparation of BB-K8 (amikacin) (author's transl)].
    Okubo H; Okamoto Y; Uba F; Ueda Y; Ueda T
    Jpn J Antibiot; 1975 Jun; 28(3):283-7. PubMed ID: 1152282
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative pharmacokinetics of amikacin after intravenous, intramuscular and subcutaneous administration].
    Leng B; Saux MC; Latrille J
    Nouv Presse Med; 1979 Oct; 8(42):3421-5. PubMed ID: 537887
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of dose in the urinary excretion of amikacin.
    Lanao JM; Pedraz JL; Navarro AS; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):538-42. PubMed ID: 6511129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evaluation of amikacin in neonates.
    Howard JB; McCracken GH
    Antimicrob Agents Chemother; 1975 Jul; 8(1):86-90. PubMed ID: 1164009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of amikacin in patients with impaired renal function.
    McHenry MC; Wagner JG; Hall PM; Vidt DG; Gavan TL
    J Infect Dis; 1976 Nov; 134 SUPPL():S343-8. PubMed ID: 993627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the toxicity of amikacin (BB-K8),III. Subacute toxicity of amikacin (BB-K8) in dogs (author's transl)].
    Matsuzaki M; Akutsu S; Yoshida A; Onodera K; Sekino M
    Jpn J Antibiot; 1975 Aug; 28(4):458-84. PubMed ID: 1160143
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics and dose calculations of amikacin in the newborn.
    Sardemann H; Colding H; Hendel J; Kampmann JP; Hvidberg EF; Vejlsgaard R
    Clin Pharmacol Ther; 1976 Jul; 20(1):59-66. PubMed ID: 1277725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative clinical pharmacology of amikacin and kanamycin in dairy calves.
    Ziv G
    Am J Vet Res; 1977 Mar; 38(3):337-40. PubMed ID: 403834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of amikacin in children with normal and impaired renal function.
    Lanao JM; Dominguez-Gil AA; Dominguez-Gil A; Málaga S; Crespo M; Santos F
    Kidney Int; 1981 Jul; 20(1):115-21. PubMed ID: 7300106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Molina HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):271-5. PubMed ID: 7107075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin serum concentrations: prediction of levels and dosage guidelines.
    Sarubbi FA; Hull JH
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):612-8. PubMed ID: 717929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.